Allergan, Inc.

NYSE: AGN
$193.02
+$0.03 (+0.0%)
Closing price May 8, 2020
A new Merrill Lynch research report includes a high-profile financial addition to the firm's US 1 portfolio of high-conviction stock picks.
Lee Jackson
Though Allergan reported better than expected quarterly results before the markets opened on Tuesday, its shares retreated.
Chris Lange
Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
Chris Lange
Botox maker Allergan said Wednesday that it is firing 1,000 employees and eliminating about 400 unfilled job openings as it tries to make good on a promise to cut up to $400 million in costs in 2018.
Paul Ausick
Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to...
Chris Lange
The top analyst upgrades, downgrades and other research calls from Thursday include Amazon, Allergan, Borg Warner, Lam Research, Mellanox Technologies and Shake Shack.
Lee Jackson
Allergan, Cemex, Delphi Technologies, and Eldorado Gold all posted new 52-week lows on Tuesday.
Paul Ausick
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
Lee Jackson
The top analyst upgrades, downgrades and other research calls from Wednesday include Allergan, Autodesk, Home Depot, Marvell, Qualcomm, UnitedHealth and Walmart.
Jon C. Ogg
Why Wall Street “Super Investors” are buying Facebook, AliBaba, Allergan, Capital One Financial, and Micron Technology.
Lee Jackson
Allergan, Immune Pharmaceuticals, Newell Brands, and Sally Beauty all posted new 52-week lows on Thursday.
Paul Ausick
The top analyst upgrades, downgrades and other research calls from Thursday include Adobe, Allergan, American Express, Baker Hughes, Nike, Northern Dynasty Minerals, Sprint and Wayfair.
Jon C. Ogg
Wednesday was a positive day for the U.S. broad markets and again all exchanges hit new all-time highs. The Dow performed especially well breaking and holding above 23,000. Crude oil posted another...
Chris Lange
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.
Jon C. Ogg
These four large cap top pick stocks would make stellar additions to growth stock portfolios. All pay dependable dividends and are good candidates to continue raising those dividends in years to come.
Lee Jackson